D-Wave Quantum and Japan Tobacco Complete Quantum AI Project

An announcement from D-Wave Quantum ( (QBTS) ) is now available.

On March 31, 2025, D-Wave Quantum Inc. and Japan Tobacco Inc.’s pharmaceutical division completed a joint proof-of-concept project using quantum computing and AI in drug discovery. This collaboration enhanced large language models with a quantum-hybrid workflow, enabling the production of novel molecular structures. The project demonstrated the potential benefits of quantum computing in generative AI for drug discovery by providing higher quality, lower energy samples. Additionally, on the same date, D-Wave and Ford Otosan announced the deployment of a hybrid-quantum application in vehicle manufacturing, improving production sequencing for the Ford Transit line. This application showcased quantum computing’s real-world impact in automotive manufacturing, highlighting its ability to optimize processes beyond classical computing capabilities.

More about D-Wave Quantum

D-Wave Quantum Inc. is a leader in the development and delivery of quantum computing systems, software, and services. It is the world’s first commercial supplier of quantum computers, building both annealing and gate-model quantum computers. The company aims to help customers realize the value of quantum computing, with its 5,000+ qubit Advantage™ quantum computers available on-premises or via the cloud.

YTD Price Performance: -21.12%

Average Trading Volume: 85,031,558

Technical Sentiment Signal: Sell

Current Market Cap: $2.21B

See more insights into QBTS stock on TipRanks’ Stock Analysis page.